Doripenem [doripenem]

topical
Terms

Doribax

 

2-(5-sulfamoylaminomethylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid
S 4661
S-4661

Definition

A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of infections such as HOSPITAL-ACQUIRED PNEUMONIA, and complicated intra-abdominal or urinary-tract infections, including PYELONEPHRITIS.

DUI
D000077726 MeSH Browser
CUI
M0260551
RN
BHV525JOBH
CAS
1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-
History note
2019 (1996)
Public note
2019; DORIPENEM was indexed under CARBAPENEMS 1996-2018

D Chemicals and Drugs
D02.065 Amides 259
D02.065.589 Lactams 143
D02.065.589.099 beta-Lactams 73
D02.065.589.099.124 Carbapenems 117
D02.065.589.099.124.150 Doripenem
D02.065.589.099.124.225 Ertapenem 1
D02.065.589.099.124.300 Thienamycins 38
D03.633.100.300 beta-Lactams 73
D03.633.100.300.124 Carbapenems 117
D03.633.100.300.124.150 Doripenem
D03.633.100.300.124.225 Ertapenem 1
D03.633.100.300.124.300 Thienamycins 38